Enveric Biosciences Inc.

NASDAQ: ENVB · Real-Time Price · USD
1.08
-0.03 (-2.70%)
At close: Aug 15, 2025, 3:57 PM
1.09
0.98%
After-hours: Aug 15, 2025, 07:16 PM EDT

Enveric Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
337.49K 408.03K 435.2K 681.61K
Gross Profit
n/a -408.03K -435.2K -681.61K
Operating Income
-9.63M -16.45M -19.96M -64.62M
Interest Income
n/a n/a 5.25 10.32
Pretax Income
-9.57M -17.26M -19.96M -56.43M
Net Income
-9.57M -17.29K -18.47M -48.98M
Selling & General & Admin
6.45M 8.79M 11.61M 20.5M
Research & Development
2.84M 7.25M 8.03M 4.79M
Other Expenses
337.49K n/a n/a 656.64K
Operating Expenses
9.63M 16.04M 19.53M 25.94M
Interest Expense
n/a 3.71K 5.25K 10.32K
Selling & Marketing Expenses
n/a -64.05K n/a n/a
Cost & Expenses
-9.63M 16.45M 19.96M 25.94M
Income Tax Expense
8.93K 28.91K -1.49M -7.45M
Shares Outstanding (Basic)
502.9K 2.53M 2.53M 472.34K
Shares Outstanding (Diluted)
502.9K 2.16M 2.08M 472.34K
EPS (Basic)
-19.04 -8.09 -7.31 -103.69
EPS (Diluted)
-19.04 -8.09 -13 -103.69
EBITDA
-9.23M -16.85M -19.52M -63.97M
EBIT
-9.57M -17.26M -19.95M -56.42M
Depreciation & Amortization
337.49K 408.03K 435.2K 681.61K